Nail dyschromia.
D000962:Antimalarials / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000150:complications; D003358:Cosmetics / Q000009:adverse effects; D003872:Dermatitis / Q000150:complications; D005260:Female; D006801:Humans; D009181:Mycoses / Q000150:complications; D009260:Nail Diseases; D010858:Pigmentation; D010859:Pigmentation Disorders / Q000139:chemically induced / Q000209:etiology*; D013754:Tetracyclines / Q000009:adverse effects; D014947:Wounds and Injuries / Q000209:etiology
D000962:Antimalarials; D000970:Antineoplastic Agents; D003358:Cosmetics; D013754:Tetracyclines